nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A personalised medicine drug sensitivity and resistance testing platform and utilisation of acoustic droplet ejection at the Institute for Molecular Medicine Finland
|
Saarela, Jani |
|
2014 |
|
1 |
p. 78- 1 p. |
artikel |
2 |
Combination screening of synthetic drugs and plant derived natural products—Potential and challenges for drug development
|
Ulrich-Merzenich, Gudrun Sigrid |
|
2014 |
|
1 |
p. 59-69 11 p. |
artikel |
3 |
Combined effect of paclitaxel and piperine on a MCF-7 breast cancer cell line in vitro: Evidence of a synergistic interaction
|
Motiwala, M.N. |
|
2015 |
|
1 |
p. 1-6 6 p. |
artikel |
4 |
Editorial
|
Ulrich-Merzenich, Gudrun |
|
2014 |
|
1 |
p. 1-2 2 p. |
artikel |
5 |
Editorial Board
|
|
|
2014 |
|
1 |
p. iii- 1 p. |
artikel |
6 |
Editorial Board
|
|
|
2015 |
|
1 |
p. iii- 1 p. |
artikel |
7 |
Editorial Board
|
|
|
2016 |
|
1 |
p. iii- 1 p. |
artikel |
8 |
Effectiveness versus toxicity: How to assess combinations?
|
Kelber, Olaf |
|
2014 |
|
1 |
p. 81-82 2 p. |
artikel |
9 |
Frequently asked questions in drug combinations and the mass-action law-based answers
|
Chou, Ting-Chao |
|
2014 |
|
1 |
p. 3-21 19 p. |
artikel |
10 |
From additivity to synergism – A modelling perspective
|
Ritz, Christian |
|
2014 |
|
1 |
p. 22-29 8 p. |
artikel |
11 |
Modelling synergistic effects of appetite regulating hormones
|
Schmidt, Julie B. |
|
2016 |
|
1 |
p. 1-2 2 p. |
artikel |
12 |
Novel options of complex combinatory screening by digital dispensing technology
|
Biegger, M. |
|
2014 |
|
1 |
p. 76-77 2 p. |
artikel |
13 |
Overcoming of P-glycoprotein-mediated multidrug resistance of tumors in vivo by drug combinations
|
Saeed, Mohamed |
|
2014 |
|
1 |
p. 44-58 15 p. |
artikel |
14 |
Searching for synergy in silico, in vitro and in vivo
|
Sucher, Nikolaus J. |
|
2014 |
|
1 |
p. 30-43 14 p. |
artikel |
15 |
Status quo and future developments of combinations of medicinal products
|
Schweim, J.K. |
|
2014 |
|
1 |
p. 70-75 6 p. |
artikel |
16 |
The development of fixed drug combinations – The example of Aspirin® Complex
|
Gessner, Uwe |
|
2014 |
|
1 |
p. 79-80 2 p. |
artikel |